Gupta P - Search Results

1

PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

Gupta P, Kathawala RJ, Wei L, Wang F, Wang X, Druker BJ, Fu LW, Chen ZS. Gupta P, et al. Cancer Lett. 2016 Dec 28;383(2):220-229. doi: 10.1016/j.canlet.2016.09.025. Epub 2016 Oct 5. Cancer Lett. 2016. PMID: 27720778

2

Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.

Anreddy N, Gupta P, Kathawala RJ, Patel A, Wurpel JN, Chen ZS. Anreddy N, et al. Among authors: gupta p. Molecules. 2014 Sep 4;19(9):13848-77. doi: 10.3390/molecules190913848. Molecules. 2014. PMID: 25191874 Free PMC article. Review.

3

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.

Kathawala RJ, Gupta P, Ashby CR Jr, Chen ZS. Kathawala RJ, et al. Among authors: gupta p. Drug Resist Updat. 2015 Jan;18:1-17. doi: 10.1016/j.drup.2014.11.002. Epub 2014 Dec 10. Drug Resist Updat. 2015. PMID: 25554624 Review.

4

Multidrug Resistance Proteins (MRPs) and Cancer Therapy.

Zhang YK, Wang YJ, Gupta P, Chen ZS. Zhang YK, et al. Among authors: gupta p. AAPS J. 2015 Jul;17(4):802-12. doi: 10.1208/s12248-015-9757-1. Epub 2015 Apr 4. AAPS J. 2015. PMID: 25840885 Free PMC article. Review.

5

A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.

Anreddy N, Patel A, Zhang YK, Wang YJ, Shukla S, Kathawala RJ, Kumar P, Gupta P, Ambudkar SV, Wurpel JN, Chen ZS, Guo H. Anreddy N, et al. Among authors: gupta p. Oncotarget. 2015 Nov 17;6(36):39276-91. doi: 10.18632/oncotarget.5747. Oncotarget. 2015. PMID: 26515463 Free PMC article.

6

Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer.

Gupta P, Jani KA, Yang DH, Sadoqi M, Squillante E, Chen ZS. Gupta P, et al. Expert Opin Drug Metab Toxicol. 2016;12(3):281-9. doi: 10.1517/17425255.2016.1145655. Epub 2016 Feb 15. Expert Opin Drug Metab Toxicol. 2016. PMID: 26799671 Review.

7

Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells.

Zhang XY, Zhang YK, Wang YJ, Gupta P, Zeng L, Xu M, Wang XQ, Yang DH, Chen ZS. Zhang XY, et al. Among authors: gupta p. Molecules. 2016 Sep 15;21(9):1236. doi: 10.3390/molecules21091236. Molecules. 2016. PMID: 27649127 Free PMC article.

8

GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance.

Gupta P, Xie M, Narayanan S, Wang YJ, Wang XQ, Yuan T, Wang Z, Yang DH, Chen ZS. Gupta P, et al. J Cell Biochem. 2017 Oct;118(10):3260-3267. doi: 10.1002/jcb.25975. Epub 2017 May 3. J Cell Biochem. 2017. PMID: 28266043 Free PMC article.

9

Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.

Wang YJ, Zhang YK, Zhang GN, Al Rihani SB, Wei MN, Gupta P, Zhang XY, Shukla S, Ambudkar SV, Kaddoumi A, Shi Z, Chen ZS. Wang YJ, et al. Among authors: gupta p. Cancer Lett. 2017 Jun 28;396:145-154. doi: 10.1016/j.canlet.2017.03.011. Epub 2017 Mar 14. Cancer Lett. 2017. PMID: 28302530 Free PMC article.

10

Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.

Wen Y, Zhao RQ, Zhang YK, Gupta P, Fu LX, Tang AZ, Liu BM, Chen ZS, Yang DH, Liang G. Wen Y, et al. Among authors: gupta p. Oncotarget. 2017 May 2;8(18):29760-29770. doi: 10.18632/oncotarget.15964. Oncotarget. 2017. PMID: 28423656 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,265 results

Search Page

Filters